Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM) Model, due to COVID-19.
More than half of U.S. adults aged 70 and older have experienced a disruption in their medical care during the first month of social distancing for COVID-19, according to a new survey by NORC at the University of Chicago, the SCAN Foundation and John A. Hartford Foundation.
The U.S. Postal Service released a temporary final rule updating its Hazardous, Restricted and Perishable Mail regulations for Category B infectious substances “to support the rapid deployment” of COVID-19 diagnostic tests through the mail during the public health emergency.
CMS last week updated its infection control guidance for home health agencies participating in Medicare and Medicaid and for religious non-medical health care institutions participating in Medicare.
The Small Business Administration and Department of the Treasury announced that SBA is now accepting and processing Paycheck Protection Program loan applications.
The Centers for Medicare & Medicaid Services April 26 announced it is reevaluating the amounts that will be paid under its Accelerated Payment Program and suspending its Advance Payment Program effective immediately.
Health care providers are eligible for reimbursement from the federal government for COVID-19 testing, treatment and related services provided to the uninsured.
The Centers for Disease Control and Prevention last week released a new tool for estimating surges in demand for hospital-based services related to COVID-19.
AHA supports extending the Comprehensive Care for Joint Replacement model for an additional three years, but only on a voluntary basis, the association told the Centers for Medicare & Medicaid Services in comments submitted.
The Food and Drug Administration issued guidance allowing patients to use certain non-invasive fetal and maternal monitoring devices in the home during the COVID-19 emergency to reduce the need for in-clinic visits.